Furthermore, our data showed that among individuals with Braak stage III–VI, those with T2DM exhibited more p-Tau-ir in the NBM compared to the non-diabetic controls, suggesting that T2DM may exacerbate neuropathological changes associated with AD. This evidence concerns the gene MAPT and type 2 diabetes mellitus.